Avara Management Ltd, Director, 10% Owner at Royalty Pharma plc (RPRX), sold 1,344,752 shares at $28.91 ($38.9M) on 2023-12-14, disclosed to the SEC on 2023-12-15.
Open-market sale of $38.9M RPRX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.95 | 307,935 | $8.9M | 22.9% |
| 2 | $28.95 | 307,935 | $8.9M | 22.9% |
| 3 | $28.91 | 364,441 | $10.5M | 27.1% |
| 4 | $28.91 | 364,441 | $10.5M | 27.1% |
| Total | $28.93 avg | 1,344,752 | $38.9M | 100% |
| Filing → |
| RPRX | SELL | 2022-09-30 | $2.7M | — | Filing → |
| RPRX | SELL | 2022-09-26 | $17.4M | — | Filing → |
| RPRX | SELL | 2022-09-09 | $42.7M | — | Filing → |